{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:38:42Z","timestamp":1792741122876,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012378","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000}}],"reference-count":115,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012378.pub2","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T11:18:32Z","timestamp":1545304712000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Inositol for subfertile women with polycystic ovary syndrome"],"prefix":"10.1002","volume":"2018","author":[{"given":"Marian G","family":"Showell","sequence":"first","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; Park Road Grafton Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Mackenzie-Proctor","sequence":"additional","affiliation":[{"name":"Auckland City Hospital; Department of Obstetrics and Gynaecology; Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Jordan","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; Park Road Grafton Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Hodgson","sequence":"additional","affiliation":[{"name":"Auckland City Hospital; Department of Obstetrics and Gynaecology; Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Farquhar","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Obstetrics and Gynaecology; Park Road Grafton Auckland New Zealand 1142"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/09513590.2012.743020","article-title":"Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study","volume":"29","author":"Artini","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"22","key":"10.1002\/14651858.CD012378.pub2-BIB0002|cit2","first-page":"3095","article-title":"Inositol: effects on oocyte quality in patients undergoing ICSI. An open study","volume":"17","author":"Brusco","year":"2013","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD012378.pub2-BIB0003|cit3","first-page":"509","article-title":"Effects of myo-inositol supplementation on oocytes' quality in PCOS patients: a double blind trial","volume":"15","author":"Ciotta","year":"2011","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD012378.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00404-013-2855-3","article-title":"The combined therapy myo-inositol plus D-chiro-inositol, rather than D-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial","volume":"288","author":"Colazingari","year":"2013","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0005|cit5","first-page":"130","article-title":"D-chiro-inositol and PCOS","volume":"32","author":"Hoxha","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"22","key":"10.1002\/14651858.CD012378.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"Article Number","DOI":"10.1155\/2016\/4378507","article-title":"Prospective randomized study on the influence of myoinositol in PCOS women undergoing IVF in the improvement of oocyte quality, fertilization rate, and embryo quality","volume":"8","author":"Lesoine","year":"2016","journal-title":"International Journal of Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD012378.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/09513590.2015.1101444","article-title":"Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome","volume":"32","author":"Pacchiarotti","year":"2015","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0008|cit8","first-page":"i101 Abstract N","article-title":"Comparison of myo-inositol plus folic acid vs clomiphene citrate for first-line treatment in women with polycystic ovary syndrome","volume":"23 Suppl 1","author":"Papaleo","year":"2008","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD012378.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.fertnstert.2008.01.088","article-title":"Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial","volume":"91","author":"Papaleo","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD012378.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s10815-014-0307-z","article-title":"Protein modification as oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin","volume":"31","author":"Piomboni","year":"2014","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/09513590903366996","article-title":"Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women","volume":"26","author":"Raffone","year":"2010","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD012378.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1757-2215-5-14","article-title":"Does ovary need D-chiro-inositol?","volume":"5","author":"Rosalbino","year":"2012","journal-title":"Journal of Ovarian Research"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0013|cit13","first-page":"452","article-title":"Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial","volume":"15","author":"Unfer","year":"2011","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0014|cit14","first-page":"E572","article-title":"Effects of myoinositol on clinical, hormonal & metabolic parameters of PCOS in comparison to metformin","volume":"131","author":"Agarwal","year":"2015","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"Article Number","DOI":"10.1155\/2016\/3204083","article-title":"A combined therapy with myo-inositol and D-chiro-inositol improves endocrine parameters and insulin resistance in PCOS young overweight women","volume":"2016","author":"Benelli","year":"2016","journal-title":"International Journal of Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0016|cit16","first-page":"425","article-title":"[Evaluation of a new association between insulin-sensitizers and alpha-lipoic acid in obese women affected by PCOS]","volume":"65","author":"Cappelli","year":"2013","journal-title":"Minerva Ginecologica"},{"issue":"10","key":"10.1002\/14651858.CD012378.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.metabol.2008.05.008","article-title":"Insulin-stimulated release of D-chiro-inositol-containing inositol-phosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome","volume":"57","author":"Cheang","year":"2008","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"6","key":"10.1002\/14651858.CD012378.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/09513590.2015.1014784","article-title":"D-chiro-Inositol and alpha lipoic acid treatment of metabolic and menses disorders in women with PCOS","volume":"31","author":"Cianci","year":"2015","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"S545","DOI":"10.1016\/S0020-7292(12)61237-5","article-title":"Myo-inositol vs D-chiro inositol in PCOS treatment","volume":"119","author":"Ciotta","year":"2012","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD012378.pub2-BIB0020|cit20","first-page":"145","article-title":"D-chiro-inositol treatment in patients with polycystic ovary syndrome","volume":"34","author":"Ciotta","year":"2012","journal-title":"Giornale Italiano di Ostetricia e Ginecologia"},{"issue":"2","key":"10.1002\/14651858.CD012378.pub2-BIB0021|cit21","first-page":"105","article-title":"Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial","volume":"13","author":"Costantino","year":"2009","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD012378.pub2-BIB0022|cit22","first-page":"41","article-title":"Insulin sensitizer and inositol in the treatment of infertile PCOS patients","volume":"34","author":"Leo","year":"2012","journal-title":"Giornale Italiano di Ostetricia e Ginecologia"},{"issue":"6","key":"10.1002\/14651858.CD012378.pub2-BIB0023|cit23","first-page":"527","article-title":"Combination inositol and glucomannan in PCOS patients","volume":"66","author":"Leo","year":"2014","journal-title":"Minerva Ginecologica"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1530\/EJE-11-0840","article-title":"Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome","volume":"166","author":"Don","year":"2012","journal-title":"European Journal of Endocrinology"},{"issue":"7","key":"10.1002\/14651858.CD012378.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/09513590.2017.1296127","article-title":"Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial.","volume":"33","author":"Emekci Ozay","year":"2017","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0026|cit26","first-page":"321","article-title":"Myo-inositol vs. D-chiro inositol in PCOS treatment","volume":"67","author":"Formuso","year":"2015","journal-title":"Minerva Ginecologica"},{"issue":"1","key":"10.1002\/14651858.CD012378.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/09513590.2016.1236078","article-title":"Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)","volume":"33","author":"Fruzzetti","year":"2017","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD012378.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/09513590801893232","article-title":"Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome","volume":"24","author":"Genazzani","year":"2008","journal-title":"Gynecological Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD012378.pub2-BIB0029|cit29","first-page":"151","article-title":"Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial","volume":"7","author":"Gerli","year":"2003","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"5","key":"10.1002\/14651858.CD012378.pub2-BIB0030|cit30","first-page":"347","article-title":"Randomized, double blind placebo-controlled trial: effects of myo-inositol on ovarian function and metabolic factors in women with PCOS","volume":"11","author":"Gerli","year":"2007","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0031|cit31","first-page":"i334 Abstract n","article-title":"Metformin versus myoinositol: which one is better in obese PCOS patients - a crossover study on clinical, endocrine and metabolic effects","volume":"29 Suppl 1","author":"Immediata","year":"2014","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD012378.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4158\/EP.8.6.417","article-title":"Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome","volume":"8","author":"Iuorno","year":"2002","journal-title":"Endocrine Practice"},{"issue":"2","key":"10.1002\/14651858.CD012378.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/cen.13366","article-title":"Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: a randomized controlled clinical trial","volume":"87","author":"Jamilian","year":"2017","journal-title":"Clinical Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD012378.pub2-BIB0034|cit34","first-page":"23","article-title":"Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition [Italian]","volume":"64","author":"Donne","year":"2012","journal-title":"Minerva Ginecologica"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"Article Number","DOI":"10.1186\/1477-7827-10-52","article-title":"Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study","volume":"10","author":"Lisi","year":"2012","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD012378.pub2-BIB0036|cit36","first-page":"(no pagination)","article-title":"Efficacy and safety of myo-inositol supplementation in the treatment of obese hirsute PCOS women: comparative evaluation with OCP+bicalutamide therapy","volume":"37 Suppl 1","author":"Moretti","year":"2016","journal-title":"Endocrine Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012378.pub2-BIB0037|cit37","first-page":"457","article-title":"Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association","volume":"67","author":"Morgante","year":"2015","journal-title":"Minerva Ginecologica"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0038|cit38","first-page":"i227","article-title":"The addiction of melatonin to myo-inositol plus folic acid improve oocyte quality and pregnancy outcome in IVF cycle. A prospective clinical trial","volume":"26","author":"Nazzaro","year":"2011","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0039|cit39","first-page":"1664","article-title":"A comparative study of myo inositol versus metformin on biochemical profile in polycystic ovarian syndrome in women","volume":"8","author":"Nehra","year":"2017","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.22159\/ijpps.2017v9i4.16359","article-title":"Comparision of myo-inositol versus metformin on anthropometric parameters in polycystic ovarian syndrome in women","volume":"9","author":"Nehra","year":"2017","journal-title":"International Journal of Pharmacy and Pharmaceutical Sciences"},{"issue":"17","key":"10.1002\/14651858.CD012378.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome","volume":"340","author":"Nestler","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012378.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S0015-0282(01)02325-1","article-title":"D-chiro-inositol (INS-1) enhances ovulatory rate in hyperandrogenemic, oligomenorrheic women with the polycystic ovary syndrome","volume":"76 Suppl 1","author":"Nestler","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012378.pub2-BIB0043|cit43","first-page":"575","article-title":"The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone","volume":"16","author":"Nordio","year":"2012","journal-title":"European Review for Medical and Ppharmacological Sciences"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0044|cit44","first-page":"137","article-title":"MYO-inositol in the treatment of women with polycystic ovary syndrome (PCOS)","volume":"32","author":"Orbetzova","year":"2016","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"Article Number","DOI":"10.1155\/2016\/3206872","article-title":"Different effects of myoinositol plus folic acid versus combined oral treatment on androgen levels in PCOS women","volume":"2016","author":"Ozay","year":"2016","journal-title":"International Journal of Endocrinology"},{"issue":"12","key":"10.1002\/14651858.CD012378.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1080\/09513590701672405","article-title":"Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction","volume":"23","author":"Papaleo","year":"2007","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD012378.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/09513590.2013.860120","article-title":"Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS","volume":"30","author":"Pizzo","year":"2014","journal-title":"Gynecological Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD012378.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/cen.13304","article-title":"Metformin vs myo-inositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study","volume":"86","author":"Tagliaferri","year":"2017","journal-title":"Clinical Endocrinology"},{"issue":"29","key":"10.1002\/14651858.CD012378.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"Article number","DOI":"10.1155\/2016\/6273298","article-title":"Myoinositol improves embryo development in PCOS patients undergoing ICSI","volume":"9","author":"Wdowiak","year":"2016","journal-title":"International Journal of Endocrinology"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0050|cit50","doi-asserted-by":"crossref","unstructured":"Llaneza P Aragon M Maldonado V Lorente J Bravo MJ Fonolla F Comparison of the effect of two combinations of myo-inositol and D-chiro inositol in women with polycystic ovary syndrome who undergo ICSI Human Reproduction 2018 i436","DOI":"10.26226\/morressier.5af300b2738ab10027aa9958"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0051|cit51","doi-asserted-by":"crossref","unstructured":"Mahey R Agrawal A Kachhawa G Kriplani I Kulshrestha V Khadgawat G To compare the effect of metformin plus myoinositol vs metformin alone in terms of clinical pregnancy rates in infertile PCOS women Human Reproduction 2018 i433 i434","DOI":"10.26226\/morressier.5af300b2738ab10027aa9949"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0052|cit52","unstructured":"IRCT2017021432525N2 Study the Effects of Pretreatment With Myoinositol on Oocyte Quality in Patients With Polycyctic Ovary Syndrome http:\/\/en.irct.ir\/trial\/25319"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0053|cit53","unstructured":"IRCT2017070234845N1 Comparison of Effectiveness of Inositol and Metformin in Infertile Women With Polycystic Ovary Syndrome (PCOS) http:\/\/en.irct.ir\/trial\/26519"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0054|cit54","unstructured":"NCT01514942 Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound Parameters https:\/\/ClinicalTrials.gov\/show\/NCT01514942"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0055|cit55","unstructured":"NCT01540747 Role of Melatonin Supplementation in Follicular Fluid of In Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome http:\/\/clinicaltrials.gov\/show\/NCT01540747"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0056|cit56","unstructured":"NCT01555190 Combination Therapy With Myo-inositol and Folic Acid Versus Myo-inositol Alone https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01555190"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0057|cit57","unstructured":"NCT02221154 Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) In Vitro Fertilization (IVF) https:\/\/ClinicalTrials.gov\/show\/NCT02221154"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0058|cit58","unstructured":"NCT02385396 Myo-inositol Therapy on the Dynamics of Embryo Development in Patients Suffering From PCOS Undergoing ICSI Treatment https:\/\/ClinicalTrials.gov\/show\/NCT02385396"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0059|cit59","unstructured":"NCT02630485 Graceful Lifestyle Changes Study for PCOS and Infertility GLC https:\/\/clinicaltrials.gov\/show\/NCT02630485"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0060|cit60","unstructured":"NCT03059173 Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome clinicaltrials.gov\/show\/NCT03059173"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0061|cit61","unstructured":"NCT03177122 Myo-Inositol-Based Co-treatment in Women With PCOS Undergoing Assisted Reproductive Technology https:\/\/clinicaltrials.gov\/show\/NCT03177122"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0062|cit62","unstructured":"NCT03201601 Evaluation of the Mixture Myoinositol:D-chiro-inositol 3.6:1 in Women With Polycystic Ovary Syndrome https:\/\/ClinicalTrials.gov\/show\/NCT03201601"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0063|cit63","doi-asserted-by":"crossref","unstructured":"Abu Hashim H Clomiphene citrate alternatives for the initial management of polycystic ovary syndrome: an evidence-based approach Archives of Gynecology and Obstetrics 2012 1737 45","DOI":"10.1007\/s00404-012-2261-2"},{"issue":"1","key":"10.1002\/14651858.CD012378.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12906-017-2011-x","article-title":"Nutritional supplements and herbal medicines for women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"17","author":"Arentz","year":"2017","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012378.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.fertnstert.2012.09.023","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"99","author":"Practice Committee of American Society for Reproductive Medicine","year":"2013","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD012378.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"12","key":"10.1002\/14651858.CD012378.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1471-0528.1993.tb15170.x","article-title":"Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage","volume":"100","author":"Balen","year":"1993","journal-title":"British Journal of Obstetrics and Gynaecology"},{"issue":"9","key":"10.1002\/14651858.CD012378.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1093\/humrep\/17.9.2219","article-title":"What is polycystic ovary syndrome? Are national views important?","volume":"17","author":"Balen","year":"2002","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD012378.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1301\/00296640260042748","article-title":"Involvement of inositol in reproduction","volume":"60","author":"Beemster","year":"2002","journal-title":"Nutrition Reviews"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Brown J Farquhar C Beck J Boothroyd C Hughes E Clomiphene and anti-oestrogens for ovulation induction in PCOS Cochrane Database of Systematic Reviews 2009 10.1002\/14651858.CD002249.pub4","DOI":"10.1002\/14651858.CD002249.pub4"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0071|cit71","doi-asserted-by":"crossref","unstructured":"Burghen GA Givens JR Kitabchi AE Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease Journal of Clinical Endocrinology and Metabolism 1980 113 6","DOI":"10.1210\/jcem-50-1-113"},{"issue":"8","key":"10.1002\/14651858.CD012378.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.fertnstert.2011.05.027","article-title":"The D-chiro-inositol paradox in the ovary","volume":"95","author":"Carlomagno","year":"2011","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0073|cit73","doi-asserted-by":"crossref","unstructured":"Ching HL Burke V Stuckey BGA Quality of life and psychological morbidity in women with polycystic ovary syndrome: body mass index, age and the provision of patient information are significant modifiers Clinical Endocrinology 2007 373 9","DOI":"10.1111\/j.1365-2265.2007.02742.x"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0074|cit74","unstructured":"https:\/\/www.covidence.org\/ COVIDENCE"},{"issue":"11","key":"10.1002\/14651858.CD012378.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"10","key":"10.1002\/14651858.CD012378.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/humrep\/del236","article-title":"Evidence of improving quality of reporting of randomized controlled trials in subfertility","volume":"21","author":"Dias","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0077|cit77","doi-asserted-by":"crossref","unstructured":"Facchinetti F Bizzarri M Benvenga S D'Anna R Lanzone A Soulage C Results From the International Consensus Conference on Myo-inositol and D-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS European Journal of Obstetrics, Gynecology, and Reproductive Biology 2015 72 6","DOI":"10.1016\/j.ejogrb.2015.09.024"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0078|cit78","doi-asserted-by":"crossref","unstructured":"Fauser BC Tarlatzis BC Rebar RW Legro RS Balen AH Lobo R Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-sponsored 3rd PCOS Consensus Workshop Group Fertility and Sterility 2012 28-38 e25","DOI":"10.1016\/j.fertnstert.2011.09.024"},{"issue":"6","key":"10.1002\/14651858.CD012378.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1055\/s-0042-100206","article-title":"Avoiding OHSS: controlled ovarian low-dose stimulation in women with PCOS","volume":"76","author":"Fischer","year":"2016","journal-title":"Geburtshilfe und Frauenheilkunde"},{"issue":"2","key":"10.1002\/14651858.CD012378.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010287.pub2","article-title":"Aromatase inhibitors for subfertile women with polycystic ovary syndrome","author":"Franik","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1002\/14651858.CD012378.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/09513590.2010.538099","article-title":"D-chiro-inositol and its significance in polycystic ovary syndrome: a systematic review","volume":"27","author":"Galazis","year":"2011","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0083|cit83","doi-asserted-by":"crossref","unstructured":"Genazzani AD Santagni S Rattighieri E Chierchia E Despini G Marini G Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients Gynecological Endocrinology 2014 438 43","DOI":"10.3109\/09513590.2014.897321"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0084|cit84","doi-asserted-by":"crossref","unstructured":"Genazzani AD Santagni S Ricchieri F Campedelli A Rattighieri E Chierchia E Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome Journal of Obstetrics & Gynaecology Research 2014 1353 60","DOI":"10.1111\/jog.12319"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0085|cit85","doi-asserted-by":"crossref","unstructured":"Glueck CJ Dharashivkar S Wang P Zhu B Gartside PS Tracy T Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy European Journal of Obstetrics, Gynecology, and Reproductive Biology 2005 206 12","DOI":"10.1016\/j.ejogrb.2005.03.010"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0086|cit86","unstructured":"GRADE Working Group, McMaster University GRADEpro GDT"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0088|cit88","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0089|cit89","doi-asserted-by":"crossref","unstructured":"Kamenov Z Kolarov G Gateva A Carlomagno G Genazzani AD Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance Gynecological Endocrinology 2015 131 5","DOI":"10.3109\/09513590.2014.964640"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0090|cit90","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6. Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0091|cit91","doi-asserted-by":"crossref","unstructured":"Lisi F Pretreatment with myo-inositol in patients undergoing gonadotropin multiple follicular stimulation for IVF Acta Medica International 2016 8 10","DOI":"10.5530\/ami.2016.1.4"},{"issue":"11","key":"10.1002\/14651858.CD012378.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"765","DOI":"10.6061\/clinics\/2015(11)09","article-title":"Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice","volume":"70","author":"Melo","year":"2015","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"5","key":"10.1002\/14651858.CD012378.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.rbmo.2017.07.005","article-title":"Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Mendoza","year":"2017","journal-title":"Reproductive Biomedicine Online"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1472-6483(10)60248-9","article-title":"Treatment of hirsutism with myo-inositol: a prospective clinical study","volume":"17","author":"Minozzi","year":"2008","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0095|cit95","doi-asserted-by":"crossref","unstructured":"Minozzi M Nordio M Pajalich R The combined therapy myo-inositol plus D-chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients European Review for Medical & Pharmacological Sciences 2013 537 40","DOI":"10.1155\/2013\/424163"},{"issue":"6","key":"10.1002\/14651858.CD012378.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD012378.pub2-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007506.pub3","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD012378.pub2-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003053.pub6","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Morley","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0099|cit99","doi-asserted-by":"crossref","unstructured":"Nestler JE Unfer V Reflections on inositol(s) for PCOS therapy: steps toward success Gynecological Endocrinology 2015 501 5","DOI":"10.3109\/09513590.2015.1054802"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0100|cit100","unstructured":"Papaleo E Molgora M Quaranta L Pellegrino M De Michele F Myo-inositol products in polycystic ovary syndrome (PCOS) treatment: quality, labeling accuracy, and cost comparison European Review for Medical & Pharmacological Sciences 2011 165 74"},{"issue":"3","key":"10.1002\/14651858.CD012378.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/1471-0528.14754","article-title":"Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials","volume":"125","author":"Pundir","year":"2018","journal-title":"BJOG"},{"issue":"2","key":"10.1002\/14651858.CD012378.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/hmbci-2017-0067","article-title":"Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature","volume":"34","author":"Regidor","year":"2018","journal-title":"Hormone Molecular Biology and Clinical Investigation"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0103|cit103","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0104|cit104","doi-asserted-by":"crossref","unstructured":"Rotterdam EA-SPCWG Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertility and Sterility 2004 19 25","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"issue":"4","key":"10.1002\/14651858.CD012378.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/humupd\/dmn011","article-title":"Oxidative stress and antioxidants: exposure and impact on female fertility","volume":"14","author":"Ruder","year":"2008","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0106|cit106","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) http:\/\/www.sign.ac.uk\/methodology\/filters.html"},{"issue":"8","key":"10.1002\/14651858.CD012378.pub2-BIB0107|cit107","first-page":"QC10","article-title":"Comparison of the effect of clomiphene-estradiol valerate vs letrozole on endometrial thickness, abortion and pregnancy rate in infertile women with polycystic ovarian syndrome","volume":"10","author":"Seyedoshohadaei","year":"2016","journal-title":"Journal of Clinical and Diagnostic Research"},{"issue":"2","key":"10.1002\/14651858.CD012378.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.gene.2015.11.033","article-title":"Polymorphisms and haplotypes of insulin-like factor 3 gene are associated with risk of polycystic ovary syndrome in Indian women","volume":"577","author":"Shaikh","year":"2016","journal-title":"Gene"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0109|cit109","first-page":"5469409","article-title":"Inositol and in vitro fertilization with embryo transfer. [Review]","volume":"1","author":"Simi","year":"2017","journal-title":"International Journal of Endocrinology"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0110|cit110","doi-asserted-by":"crossref","unstructured":"Tarlatzis BC Fauser BC Legro RS Norman RJ Hoeger K Pasquali R Consensus on infertility treatment related to polycystic ovary syndrome Human Reproduction 2008 462 77","DOI":"10.1093\/humrep\/dem426"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0111|cit111","doi-asserted-by":"crossref","unstructured":"Unfer V Carlomagno G Dante G Facchinetti F Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials Gynecological Endocrinology 2012 509 15","DOI":"10.3109\/09513590.2011.650660"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0112|cit112","doi-asserted-by":"crossref","unstructured":"Unfer V Porcaro G Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome Expert Review of Clinical Pharmacology 2014 623 31","DOI":"10.1586\/17512433.2014.925795"},{"issue":"5","key":"10.1002\/14651858.CD012378.pub2-BIB0113|cit113","first-page":"495-502. Erratu","article-title":"Ovulation induction in polycystic ovary syndrome","volume":"32","author":"Vause","year":"2010","journal-title":"Journal of Obstetricians and Gynaecolists of Canada"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0114|cit114","doi-asserted-by":"crossref","unstructured":"Vitek W Alur S Hoeger KM Off-label drug use in the treatment of polycystic ovary syndrome Fertility and Sterility 2015 605 11","DOI":"10.1016\/j.fertnstert.2015.01.019"},{"key":"10.1002\/14651858.CD012378.pub2-BIB0115|cit115","first-page":"j138","article-title":"Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis","volume":"356","author":"Wang","year":"2017","journal-title":"BMJ (Clinical research ed.)"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012378.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T15:02:26Z","timestamp":1735916546000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012378.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":115,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012378.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,20]]}}}